These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21282429)

  • 1. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.
    Patel N; Cardone K; Grabe DW; Meola S; Hoy C; Manley H; Drusano GL; Lodise TP
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1677-83. PubMed ID: 21282429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis.
    Butterfield JM; Mueller BA; Patel N; Cardone KE; Grabe DW; Salama NN; Lodise TP
    Antimicrob Agents Chemother; 2013 Feb; 57(2):864-72. PubMed ID: 23208714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis.
    Cardone KE; Lodise TP; Patel N; Hoy CD; Meola S; Manley HJ; Drusano GL; Grabe DW
    Clin J Am Soc Nephrol; 2011 May; 6(5):1081-8. PubMed ID: 21393490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysis.
    Haselden M; Leach M; Bohm N
    Ann Pharmacother; 2013 Oct; 47(10):1342-7. PubMed ID: 24259698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment.
    Chaves RL; Chakraborty A; Benziger D; Tannenbaum S
    J Antimicrob Chemother; 2014 Jan; 69(1):200-10. PubMed ID: 24030545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation.
    Lewis SJ; Jang SM; Mueller BA
    BMC Nephrol; 2023 Sep; 24(1):270. PubMed ID: 37710245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin Dose Optimization in Pediatric Staphylococcus aureus Bacteremia: A Pharmacokinetic/Pharmacodynamic Investigation.
    Olney KB; Howard JI; Burgess DS
    J Clin Pharmacol; 2024 Jul; 64(7):860-865. PubMed ID: 38497326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients.
    Salama NN; Segal JH; Churchwell MD; Patel JH; Gao L; Heung M; Mueller BA
    Nephrol Dial Transplant; 2010 Apr; 25(4):1279-84. PubMed ID: 20007981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.
    Salama NN; Segal JH; Churchwell MD; Patel JH; Gao L; Heung M; Mueller BA
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1190-4. PubMed ID: 19541812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ; Mueller BA
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations.
    Bhavnani SM; Ambrose PG; Hammel JP; Rubino CM; Drusano GL
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1600-7. PubMed ID: 26711755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Falcone M; Russo A; Venditti M; Novelli A; Pai MP
    Clin Infect Dis; 2013 Dec; 57(11):1568-76. PubMed ID: 24046298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin Pharmacokinetics in Adolescents Undergoing Hemodialysis and Peritoneal Dialysis: A Case Series With Pharmacokinetic Modeling.
    Lim SY; Lewis T; Woo S; Turman M; Bourne DWA; Burton ME; Rianthavorn P
    J Pediatr Pharmacol Ther; 2021; 26(2):123-132. PubMed ID: 33603575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of daptomycin in critically ill patients.
    Soraluce A; Asín-Prieto E; Rodríguez-Gascón A; Barrasa H; Maynar J; Carcelero E; Soy D; Isla A
    Int J Antimicrob Agents; 2018 Aug; 52(2):158-165. PubMed ID: 29572042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy.
    Xu X; Khadzhynov D; Peters H; Chaves RL; Hamed K; Levi M; Corti N
    Br J Clin Pharmacol; 2017 Mar; 83(3):498-509. PubMed ID: 27628437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin Exposure Prediction With a Limited Sampling Strategy.
    De Gregori S; Seminari E; Capone M; Giordani P; Bruno R; De Silvestri A
    Ther Drug Monit; 2024 Aug; 46(4):537-542. PubMed ID: 38666474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy.
    Rehm S; Campion M; Katz DE; Russo R; Boucher HW
    J Antimicrob Chemother; 2009 May; 63(5):1034-42. PubMed ID: 19264792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/Pharmacodynamic Analysis of Daptomycin Against Staphylococcus aureus and Enterococcus faecium in Pediatric Patients by Monte Carlo Simulation.
    Wei XC; Zhao MF; Li X; Xiao X
    J Clin Pharmacol; 2020 Jun; 60(6):768-774. PubMed ID: 32080861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous daptomycin in Japanese pediatric patients: Pharmacokinetic comparisons supporting dosing recommendations in Japanese pediatric patients.
    Ishii M; Orito Y; Shiomi M; Wrishko RE; Yoshitsugu H
    J Infect Chemother; 2023 Jun; 29(6):592-598. PubMed ID: 36868408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: daptomycin as a motivating example.
    Pai MP; Russo A; Novelli A; Venditti M; Falcone M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3162-7. PubMed ID: 24663017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.